Aaron R Mangold - JoVE Visualize

Showing results (81-90 of 85) with videos related to

Pageof 9

Sort By:

You have reached the last page of results.This site can display upto 85 results.

JAMA Dermatology|July 20, 2022

Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical TrialEllen J Kim, Aaron R Mangold, Jennifer A DeSimone, et al.

The New England Journal of Medicine|March 30, 2026

A Phase 3 Trial of Brepocitinib in DermatomyositisRuth Ann Vleugels, Julie J Paik, Iazsmin Bauer Ventura, et al.

The British Journal of Dermatology|October 22, 2024

Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanomaErin McGillivray, Karam Ashouri, Eftychia Chatziioannou, et al.

Cancer|October 4, 2018

Chemoprevention agents for melanoma: A path forward into phase 3 clinical trialsJoanne M Jeter, Tawnya L Bowles, Clara Curiel-Lewandrowski, et al.

Melanoma Management|August 1, 2017

Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversyMariah M Johnson, Sancy A Leachman, Lisa G Aspinwall, et al.

Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:

Pageof 9

You have reached the last page of results.This site can display upto 85 results.

JAMA Dermatology|July 20, 2022

Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical TrialEllen J Kim, Aaron R Mangold, Jennifer A DeSimone, et al.

The New England Journal of Medicine|March 30, 2026

A Phase 3 Trial of Brepocitinib in DermatomyositisRuth Ann Vleugels, Julie J Paik, Iazsmin Bauer Ventura, et al.

The British Journal of Dermatology|October 22, 2024

Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanomaErin McGillivray, Karam Ashouri, Eftychia Chatziioannou, et al.

Cancer|October 4, 2018

Chemoprevention agents for melanoma: A path forward into phase 3 clinical trialsJoanne M Jeter, Tawnya L Bowles, Clara Curiel-Lewandrowski, et al.

Melanoma Management|August 1, 2017

Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversyMariah M Johnson, Sancy A Leachman, Lisa G Aspinwall, et al.

Pageof 9